argenx SE | ARGX - Current Liabilities

Stock Price
703.20
Daily Change
-19.20 -2.66%
Monthly
0.75%
Yearly
16.66%
Q1 Forecast
704.56

argenx SE reported $1.04B in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
AstraZeneca USD 30.62B 3.44B Dec/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
UCB EUR 3.53B 731M Dec/2024